Summary/Conclusion
The use of IORT to deliver high single fraction doses precisely limited to the tumor and the possibility to tailor subsequent moderate-dose EBRT according to the spread of the disease offers a potentially curative therapy in patients who are unable to undergo radical surgery or radical EBRT due to their severe functional impairment.
Read More